Alamar Biosciences Inc (ALMR): Next-Year EPS Estimate 49.36%
As of 2026-06-11, Alamar Biosciences Inc (ALMR) has a next-year EPS growth estimate of 49.36%.
On 2026-06-03, analyst consensus for ALMR's next-year EPS growth shifted from 52.25% to 49.36% — a negative change of 2.89 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at -567.62%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 49.36%
- EPS growth this year
- -567.62%
- EPS next quarter (est)
- -$0.31
- Last price
- $22.19
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 49.36% | -567.62% | -$0.31 | $22.19 |
| 2026-06-10 | 49.36% | -567.62% | -$0.31 | $21.51 |
| 2026-06-09 | 49.36% | -567.62% | -$0.31 | $20.13 |
| 2026-06-08 | 49.36% | -567.62% | -$0.31 | $19.21 |
| 2026-06-07 | 49.36% | -567.62% | -$0.31 | $20.54 |
| 2026-06-04 | 49.36% | -567.62% | -$0.31 | $21.49 |
| 2026-06-03 | 49.36% | -567.62% | -$1.71 | $20.94 |
| 2026-06-02 | 52.25% | -560.71% | -$1.71 | $20.80 |
| 2026-06-01 | 52.25% | -560.71% | -$1.71 | $20.51 |
| 2026-05-31 | 52.25% | -560.71% | -$1.71 | $20.44 |
| 2026-05-28 | 52.25% | -560.71% | -$1.71 | $19.76 |
| 2026-05-27 | 52.25% | -560.71% | -$1.71 | $19.12 |
| 2026-05-26 | 52.25% | -560.71% | -$1.71 | $19.09 |
| 2026-05-25 | 52.25% | -560.71% | -$1.71 | $20.06 |
| 2026-05-24 | 52.25% | -560.71% | -$1.71 | $20.06 |
| 2026-05-21 | 52.25% | -560.71% | -$1.71 | $22.00 |
| 2026-05-20 | 52.25% | -560.71% | -$1.71 | $20.16 |
| 2026-05-19 | 52.25% | -560.71% | -$1.71 | $20.51 |
| 2026-05-18 | 52.25% | -560.71% | -$1.71 | $20.86 |
| 2026-05-17 | 52.25% | -560.71% | -$1.71 | $21.54 |
| 2026-05-14 | 52.25% | -560.71% | -$1.71 | $22.51 |
| 2026-05-13 | 52.25% | -560.71% | -$1.71 | $23.41 |
| 2026-05-12 | 48.89% | -120.60% | -$1.70 | $22.97 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Alamar Biosciences Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Alamar Biosciences Inc (ALMR) has a next-year EPS growth estimate of 49.36%, based on analyst consensus.
When was the latest EPS estimate revision for ALMR?▾
The most recent revision occurred on 2026-06-03, when analysts adjusted the next-year EPS growth estimate from 52.25% to 49.36%.
What sector and industry does Alamar Biosciences Inc belong to?▾
Alamar Biosciences Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ALMR appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Alamar Biosciences Inc (ALMR) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports